Measles infection in neonates ranges from asymptomatic to severe disease, requiring high clinician vigilance, prompt ...

Infants who received the MenACWY-TT vaccine demonstrated robust antibody responses against hypervirulent meningococcal ...

The LP.8.1-adapted BNT162b2 COVID-19 vaccine elicited a strong immune response and showed an acceptable safety profile in ...

Seasonal influenza vaccination reduces the risk for pediatric ED/UC visits, especially in children younger than 5 years.

Evidence of HIV-1 is uncommon among individuals receiving long-acting cabotegravir (LA CAB) for pre-exposure prophylaxis ...

FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.

The recombinant zoster vaccine protects adults with HIV against cardiovascular complications such as incident heart failure ...

An infectious disease expert discusses using motivational interviewing and empathetic communication to address vaccine ...

META Older Latino adults show high motivation for RSV vaccination but face significant barriers to actual immunization.

Treatment-experienced patients with HIV and viremia achieve high virologic suppression with long-acting CAB/RPV.

Patient COVID-19 status does not significantly alter the microbiology of device-associated hospital-acquired infections or ...

Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...